Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: a retrospective study

Luo, Fangyuan; Xie, Liangdi; Xie, Ping; Liu, Siwei; Zhu, Yi

doi:10.1016/j.tjog.2016.11.004

Cited by 31 publications

(35 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…19 In a retrospective study by Fangyuan Luo et al, intra-operative aortic balloon occlusion was done before uterine incision and recorded less blood loss. 27 In present study 65.6% patients in bilateral ligation group received no blood transfusion when compared to 33.3% in control group. 41.67% patients in control group received 4 units of red blood cell transfusion and none required transfusion of more than 3 units in bilateral ligation group.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 44%

“…21 In the study of intra operative aortic balloon occlusion by Fangyuan Luo et al, hysterectomy was done in 11.6% and four of them had placenta percreta. 27 Hysterectomy was 2.7% in the internal iliac balloon catheterization study by Yao Fan et al 19 In our study one patient (1.9%) was admitted to ICU for anaesthetic complication. From control group one patient (8.33%) had massive haemorrhage and multiple units of blood transfusion and shifted to ICU.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 48%

“…19,27 There was no surgery related complication in our study group. In the control group there was one case of bladder injury.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 58%

“…21 In aortic balloon occlusion group, four (9.3%) patients were transferred to ICU after caesarean section. 27 Interventional radiology procedures involve two steps. After catheterization in the radiology department, the patients are shifted to the operation theatre for caesarean section.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 99%

“…Arterial thrombosis is a known catheter related complication. 27 Our procedure is a simple technique and can be trained easily and also cost effective.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 99%

See 4 more Smart Citations

Effectiveness of ligation of uterine vessels prior to uterine incision for major placenta previa on reducing maternal morbidity without increasing neonatal morbidity

Shantha

Priyadarshini

Dharshini

et al. 2018

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Placenta previa causes massive obstetric haemorrhage and severe maternal morbidity. The objective is to analyse the effectiveness of uterine vessels (artery and vein) ligation before uterine incision in reducing blood loss and hysterectomy during caesarean section for major placenta previa without increasing morbidity in the newborn.Methods: A retrospective analysis of caesarean section for major placenta previa from 2002 to 2017 was done. Uterine vessels ligation before uterine incision was done in 52 patients. In 19 patients unilateral and in 33 patients bilateral uterine vessels ligation was done before uterine incision. In control group, 12 patients with major placenta previa uterine vessels were ligated after the removal of the placenta. The blood loss, blood transfusion, maternal morbidity and NICU admission of the newborns were compared.Results: The mean blood loss was 1002 ml in unilateral, 793 ml in bilateral uterine vessels ligation group, compared to 2191 ml in the control group. The mean blood transfusion volume 0.89 units in unilateral 0.60 units in bilateral ligation group while 2.33 units in the control group. The difference in blood loss and blood transfusion were statistically significant. Out of 52 babies, only 6 babies were admitted in NICU for mild depression with stay less than 3 days.Conclusions: Uterine vessels ligation before uterine incision reduces blood loss and hysterectomy during caesarean section for placenta previa without increasing the morbidity in the newborns.

show abstract

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 44%

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 48%

“…19,27 There was no surgery related complication in our study group. In the control group there was one case of bladder injury.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 58%

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 99%

“…Arterial thrombosis is a known catheter related complication. 27 Our procedure is a simple technique and can be trained easily and also cost effective.…”

Section: Effect Of Uterine Vessels Ligation On Maternal Morbiditymentioning

confidence: 99%

See 3 more Smart Citations

Effectiveness of ligation of uterine vessels prior to uterine incision for major placenta previa on reducing maternal morbidity without increasing neonatal morbidity

Shantha

Priyadarshini

Dharshini

et al. 2018

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

show abstract

FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management,

Allen

Jauniaux

Hobson

et al. 2018

Intl J Gynecology & Obste

289

282

View full text Add to dashboard Cite

High‐intensity focused ultrasound in management of placenta accreta spectrum: A systematic review

Elazeem

Saad

Ahmed

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Background: High-intensity focused ultrasound (HIFU) is a non-invasive procedure that has been studied in the management of placenta accreta spectrum (PAS). Objective: To appraise HIFU in the management of PAS and highlight the restrictions on converting uterus-preserving studies into evidence-based practice. Search strategy: A search on Scopus, Cochrane, PubMed and Web of Science was conducted from date of inception to January 2020. Selection criteria: Studies on using HIFU in the management of PAS were eligible. Review articles, conference papers, and case reports were excluded. Data collection: A standardized sheet was used to abstract data from eligible studies. CON-PAS registry was used to include studies on other conservative modalities. Results: Four studies were eligible (399 patients). Average residual placental volume was 61.74 cm 3 (6.01-339 cm 3). Treatment was successful in all patients. Normal menstruation recovered after 48.8 days (15-150 days). No major complications were encountered. Sixty-one studies were retrieved from the CON-PAS registry; uterine artery embolization (23 studies), balloon placement (15 studies), compression sutures (10 studies), placenta in situ (7 studies), and uterine resection (6 studies) were successful in 83.7%, 92.9%, 87.9%, 85.2%, and 79.3% of cases, respectively. Conclusions: HIFU may fit certain clinical situations in the management of PAS. A global research strategy is recommended to incorporate conservative approaches within a comprehensive management protocol.

show abstract

Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: a retrospective study

Abstract: Intraoperative aortic balloon occlusion is a relatively safe method for treating placenta previa and/or placenta accreta during scheduled and emergency CS and might be helpful to prevent hysterectomy and embolization in women wishing to preserve fertility.

Cited by 31 publications

References 30 publications

Effectiveness of ligation of uterine vessels prior to uterine incision for major placenta previa on reducing maternal morbidity without increasing neonatal morbidity

Effectiveness of ligation of uterine vessels prior to uterine incision for major placenta previa on reducing maternal morbidity without increasing neonatal morbidity

FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management,

High‐intensity focused ultrasound in management of placenta accreta spectrum: A systematic review

Contact Info

Product

Resources

About